Biotronik: Two Physician-Payment Settlements Eight Years Apart

Biotronik kickback settlements required the company to pay $4.9 million in 2014 and $12.95 million in 2022 to resolve allegations that it paid doctors to choose its cardiac devices. The earlier case concerned expensive meals and inflated advisory-board payments. The later case reached a new employee training program in which physicians allegedly received payments for excessive, useless or nonexistent training. For someone inside device sales or clinical support, the question is familiar: was the company paying for the doctor’s work, or for the doctor’s business?

Biotronik, based in Lake Oswego, Oregon, manufactures and sells implantable cardiac devices, including pacemakers and defibrillators. Both settlements concerned alleged payments influencing which devices physicians used, followed by claims to Medicare and Medicaid. A former employee brought the earlier whistleblower case. Former independent sales representatives brought the later one.

The Earlier Settlement Covered Meals and Advisory-Board Payments

The Department of Justice’s November 6, 2014 announcement described an alleged effort to keep physicians using Biotronik devices or persuade them to switch to the company. The benefits went to electrophysiologists and cardiologists practicing in Nevada and Arizona.

The government alleged that Biotronik paid the implanting physicians through repeated meals at expensive restaurants and inflated payments for membership on a physician advisory board. The devices included pacemakers, defibrillators and cardiac resynchronization therapy devices. Hospitals and ambulatory surgery centers then allegedly submitted false claims for the implantations.

A federal court’s account of the earlier settlement, written in a separate Biotronik case, adds a useful detail. It described the settled allegations as including monthly advisory-board payments without proper documentation of specific work performed. That gets closer to what an employee would recognize: a recurring payment, a professional title and a missing account of what the company received in return.

The former employee brought a qui tam case under the False Claims Act, and the United States joined some of the allegations. Biotronik allegedly paid the person making the implant choice, while a different institution sent the government the bill.

The Later Settlement Put Employee Training at the Center

The July 22, 2022 settlement announcement described payments to favored physicians to induce and reward their use of Biotronik’s pacemakers, defibrillators and other cardiac devices. This time, a central payment channel was the company’s new employee training program.

The direction of the training matters. Under the alleged arrangement, physicians were paid to teach Biotronik’s employees. The government alleged that the company paid for excessive numbers of trainings and, in some instances, events that never happened or provided little or no value to the trainees.

The Department of Justice alleged that Biotronik continued making the payments despite its compliance department’s warnings about salespeople’s influence over physician selection and the overuse of training payments.

Under the alleged arrangement, a salesperson could influence which customer received paid work from the manufacturer whose devices that customer chose. The alleged benefit traveled through an internal employee program, but the commercial incentive reached the physician outside it.

The Complaint Describes a Fee Attached to the Implant

The whistleblowers’ amended complaint alleged that Biotronik contracted with physician customers as consultants and paid them $400 or more per pacemaker or defibrillator implant to let an employee stand behind them and watch. The complaint described some physicians demanding a trainee at nearly every Biotronik implant so they could receive the payment.

That account makes the allegedly excessive training concrete. The employee’s presence supplied the reason for paying the physician. More paid appearances could follow more implant procedures, even where the whistleblowers said little teaching took place.

The complaint also described sales representatives seeking trainees for their physician customers’ scheduled procedures. In one example, it quoted a representative’s message to the training coordinator asking whether a trainee was available for a pacemaker implant the next morning. The alleged demand for training was being driven from the customer account toward the training department.

Certification Allegedly Would End the Payments

The complaint alleged that a training specialist discouraged grades that would let a trainee finish certification, because certification would end that employee’s availability for paid physician training. It described a March 2016 email about grading trainees and explained the consequence: qualify employees too quickly, and the company could run short of people to send to the paid cases.

A training program is supposed to produce trained employees. In this allegation, finishing the training got in the way of paying the customer.

The complaint described another conflict between training oversight and sales. A high-volume physician was allegedly rejected for further trainer work after receiving training payments on too many cases. Sales managers and representatives later sought to nominate the physician again because they did not want an angry customer who expected those payments.

These allegations give the compliance concerns a practical shape. The relevant decisions included who qualified as a trainer, whether an employee still needed instruction, and what happened when the training department tried to stop paying a physician. The program’s name tells less than those decisions do.

Training Forms That Claimed Attendance

The complaint also challenged the paperwork used to support the payments:

The surrounding account describes a training specialist instructing that only particular experienced representatives accompany trainees on a customer’s implant cases. According to the complaint, a sales representative instead signed documents as though he had been present. In a separate example, the complaint recounted a former field clinical employee’s report that staff were instructed to fill out forms claiming attendance at physician offices when they had not been there.

That is a different allegation from too many training sessions. One concerns the value and frequency of the supposed teaching. The other concerns whether the people named on the paperwork attended at all. Both matter to a payment justified as compensation for teaching an employee.

The document trail reaches beyond a check to a physician. A training nomination says who was selected. A grading record says whether the employee still needed training. An attendance form says who was present. The complaint alleged that decisions at each of those points helped keep physician payments going.

Brief Conference Appearances, Extensive Benefits

The government also alleged that Biotronik paid for physicians’ holiday parties, winery tours and lavish meals with no legitimate business purpose. The later settlement also covered allegations of international business-class airfare and honoraria paid in exchange for brief appearances at international conferences.

The complaint described a holiday party for physician customers whose attendees included family and guests. It alleged that a sales representative submitted a false expense report and sign-in sheets, leaving some actual guests off the report and adding Biotronik employees who had not attended. The party was then allegedly reported as an office training event.

For a sales or compliance employee, that means the same physician relationship could appear in several places: training records, event expenses and conference arrangements. The practical connection is the customer receiving the benefit and the device business the government alleged the company sought in return.

How Physician Payments Reached Medicare and Medicaid

The alleged path to Medicare and Medicaid ran from Biotronik’s payment to the physician’s device choice to the institution’s claim for the implant procedure. The earlier settlement specifically identified hospitals and ambulatory surgery centers as the submitters of the allegedly false claims. The later settlement included Medicaid claims partly funded by Arizona, California, Illinois, Missouri and Nevada.

That path follows how the implant business works. The Office of Inspector General’s alert on physician-owned device entities explains that implantable devices are physician preference items: the physician may make or strongly influence the choice of brand and type, even though the institution buys the device. A manufacturer seeking more business has a reason to focus on that choice.

Medicare usually includes the device’s cost in its payment for the procedure or hospital stay. The manufacturer earns revenue from the device sale. The institution bills for the care. That separation explains why the government’s allegations connect a manufacturer’s physician payments to claims submitted by hospitals or surgery centers.

Sales representatives also work close to the moment of use. A Senate Finance Committee staff report on implant distribution describes employees and independent agents supplying hospitals with devices, managing stock and helping with instrumentation in the operating room. Their work can place them where the sale, the physician’s choice and the implant meet.

In Biotronik’s alleged training arrangement, the representative’s presence had another purpose: it could justify a payment back to the physician choosing the product. Patients depend on that choice being made for their care. Taxpayers fund the resulting Medicare and Medicaid claims. The alleged payment for choosing Biotronik also put competing devices at a disadvantage.

Studies and Registries Have Carried Similar Allegations

Physician training is one way a device company can put a professional purpose around a payment to a customer. In a separate cardiac-device case, St. Jude Medical paid $16 million in 2011 to settle allegations involving post-market studies and a device registry used to induce pacemaker and defibrillator implants.

The government alleged that St. Jude collected information from participating physicians while knowingly using the programs to increase device sales by paying those physicians to select its products. The collection of information and the alleged sales inducement operated together.

The connection to Biotronik is the payment’s stated purpose and its alleged commercial purpose. One case concerned research and registry participation. The later Biotronik settlement concerned employee training. An insider may know both what work a program actually required and why the sales team wanted a particular physician paid. That knowledge gets underneath the program’s professional title.

What Evidence Is Needed to Prove Fraud?

The Biotronik complaint drew on ordinary sales and training records: nominations, emails, employee evaluations and forms saying who attended. Our whistleblower experts work with you to assess what those records and your experience can show about physician payments and government health care claims.

How Much Is a Whistleblower Claim Worth?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In the later Biotronik case, the Department of Justice announced approximately $2.1 million collectively for the former independent sales representatives as their share of the recovery.

Their position inside the sales business mattered to the account they brought. The complaint went beyond identifying payments to describing training assignments, certification decisions and paperwork that purported to record attendance. Those are the details that can turn a suspicious expense into an account of how a physician-payment program operated.

You Know What the Training Was For

If you saw training fees follow implant business, or attendance forms bear little resemblance to who was there, speak to one of our Whistleblower Experts about what the training payments bought. We build your strongest medical device whistleblower case around the decisions you witnessed and bring in medical device kickback whistleblower lawyers who understand how physician payments reach government claims. We stay beside you through the case, with your knowledge of the business at its center.